Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

In-Vitro and In-Vivo Behaviors of Poly(Glycolide-Caprolactone) Copolymer for Bioabsorbable Suture Materials

Synthesis of Poly(glycolide-Caprolactone) Copolymers for Application As Bioabsorbable Suture Materials

[Preliminary Evaluation of the Biological Properties of Poly-Lactide-co-glycolic Acid (PLGA) Knitted Mesh].

Degradation Behaviors of Bioabsorbable P3/4hb Monofilament Suture in Vitro and in Vivo

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

[In vitro studies of the mechanical load capability of resorbable monofilament suture materials]

Synthesis of a novel monofilament bioabsorbable suture for biomedical applications

Preclinical Animal Study and Human Clinical Trial Data of Co-Electrospun Poly(l-Lactide-co-caprolactone) and Fibrinogen Mesh for Anterior Pelvic Floor Reconstruction.

Nano-Mechanical Studies on Polyglactin Sutures Subjected to in Vitro Hydrolytic and Enzymatic Degradation.

Composite suture material based on polylactide accelerates the healing of surgical wounds in in vivo experiment

Bioactive coatings on biopolymer materials: evaluation of mechanical, physical, thermal, and in vitro properties

In Vitro and In Vivo Biosafety Analysis of Resorbable Polyglycolic Acid-Polylactic Acid Block Copolymer Composites for Spinal Fixation

Surface Coating Prolongs the Degradation and Maintains the Mechanical Strength of Surgical Suture in Vivo.

Structure, physical properties, biocompatibility and in vitro / vivo degradation behavior of anti-infective polycaprolactone-based electrospun membranes for guided tissue/bone regeneration

In Vivo Degradation Studies of PGA-PLA Block Copolymer and Their Histochemical Analysis for Spinal-Fixing Application

Modification of the properties of a suture thread with a tough gel coating: A baseline ex-vivo study

Evaluation of PHBHHx and PHBV/PLA Fibers Used As Medical Sutures.

Preparation Biocompatibility Evaluation on Plla Braided Nanofibers Suture

In Vitro and in Vivo Degradability and Cytocompatibility of Poly(l-Lactic Acid) Scaffold Fabricated by a Gelatin Particle Leaching Method

Sub-micron scale mechanical characterization of polyglactin sutures subjected to hydrolysis and enzymatic degradation

In vitro cytocompatibility of triclosan coated Polyglactin910 sutures